Filing Details
- Accession Number:
- 0001104659-23-028603
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 20:00:56
- Reporting Period:
- 2023-02-27
- Accepted Time:
- 2023-03-03 20:00:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651407 | Checkpoint Therapeutics Inc. | CKPT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434718 | Iii F James Oliviero | 95 Sawyer Rd, Suite 110 Waltham MA 02453 | Ceo, President And Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-27 | 5,548 | $4.65 | 134,573 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-02-27 | 15,000 | $0.00 | 149,573 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-03-02 | 5,483 | $5.00 | 144,090 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- In connection with the vesting of 14,950 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $4.65 to $4.6833. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes shares of restricted common stock, which vest over various time periods.
- Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on February 27, 2023.
- In connection with the vesting of 15,000 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $5.00 to $5.03. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
